Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Depreciation & Amortization (CF): 2020-2025

Historic Depreciation & Amortization (CF) for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to $17,000.

  • Biofrontera's Depreciation & Amortization (CF) fell 15.00% to $17,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $94,000, marking a year-over-year increase of 13.25%. This contributed to the annual value of $600,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Biofrontera's Depreciation & Amortization (CF) amounted to $17,000 in Q3 2025, which was down 22.73% from $22,000 recorded in Q2 2025.
  • Biofrontera's Depreciation & Amortization (CF)'s 5-year high stood at $33,000 during Q1 2021, with a 5-year trough of $17,000 in Q3 2025.
  • In the last 3 years, Biofrontera's Depreciation & Amortization (CF) had a median value of $21,000 in 2024 and averaged $22,000.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first decreased by 21.21% in 2022, then surged by 42.86% in 2024.
  • Biofrontera's Depreciation & Amortization (CF) (Quarterly) stood at $22,000 in 2021, then fell by 4.55% to $21,000 in 2022, then remained steady at $21,000 in 2023, then skyrocketed by 42.86% to $30,000 in 2024, then declined by 15.00% to $17,000 in 2025.
  • Its Depreciation & Amortization (CF) stands at $17,000 for Q3 2025, versus $22,000 for Q2 2025 and $25,000 for Q1 2025.